Turnaround times
IGENZ participates in GenQA Quality Assurance scheme (among others) and therefore where appropriate abides by the reporting time guidelines established by the Association for Clinical Genomics (ACG), UK.
PRENATAL DIAGNOSIS |
|||
SAMPLE TYPE |
URGENT REFERRAL |
ROUTINE REFERRAL |
SAMPLE TYPE |
|
Rapid aneuploidy (FISH testing) |
Amnio, CVS, Foetal Blood |
95% within 3 working days |
N/A |
|
Rapid karyotyping |
Amnio, CVS, Foetal Blood |
95% within 14 calendar days |
N/A |
POSTNATAL DIAGNOSIS |
|||
SAMPLE TYPE |
URGENT REFERRAL |
ROUTINE REFERRAL |
SAMPLE TYPE |
|
Rapid aneuploidy testing |
Blood |
95% within 3 working days |
N/A |
|
Karyotype result |
Blood |
95% within 10 calendar days |
95% within 28 calendar days |
HAEMATOLOGY/LEUKAEMIA |
|||
|
SAMPLE TYPE |
URGENT REFERRAL |
ROUTINE REFERRAL |
SAMPLE TYPE |
|
Rapid FISH testing |
Bone Marrow/Blood |
95% within 3 working days |
N/A |
|
Karyotype result |
Bone Marrow/Blood |
95% within 14 calendar days1 |
95% within 21 working days |
MOLECULAR ANALYSIS |
|||
SAMPLE TYPE |
URGENT REFERRAL |
ROUTINE REFERRAL |
SAMPLE TYPE |
|
MicroARRAY testing2 |
FFPE |
95% within 15 calendar days3 |
95% within 28 calendar days3 |
|
Oncology – MassARRAY testing4 |
FFPE/Peripheral Blood |
95% within 4 calendar days |
95% within 7 calendar days |
1Note: A diagnostic FISH result is adequate in this category, with confirmatory cytogenetics treated as for routine referrals.
2MicroARRAY analysis to undertake genome wide copy number and loss or gain of chromosomes is not well defined using ACG best practice guidelines therefore the HGSA guidelines have been used.
3Molecular oncology analysis guidelines using MassARRAY techniques are not well established therefore IGENZ abides by their own turnaround time objectives defined by management.
4 Due to the requirement to batch test, the turnaround times often exceed 15 or 28 calendar days. However, the referring clinician is aware of this and if required urgently, the test would be run straight away with an incomplete batch.
